pharma

16

Sep'21

The non-hormonal therapies market is growing at an annualized rate of 21.7%, claims Roots Analysis

Driven by the potential to confer safe and sustained therapeutic effects for clinical conditions unique to women, the non-hormonal therapies …

Read More

13

Sep'21

The study features in-depth analyses, highlighting the capabilities of a diverse set of biopharmaceutical CMOs.

Bispecific antibody therapeutics represent a transformative approach to modern treatment; over the years, this upcoming class of ‘two-target’ artificially engineered …

Read More

13

Sep'21

The bispecific antibody therapeutics market is estimated to be worth USD 6.9 billion in 2030

Bispecific antibody therapeutics represent a transformative approach to modern treatment; over the years, this upcoming class of ‘two-target’ artificially engineered …

Read More

10

Sep'21

STING Pathway Targeting Therapeutics and Technologies, 2020-2030 by Roots Analysis

STING, having generated significant interest within the medical research community, is currently considered one of the fastest growing areas of …

Read More

09

Sep'21

Peptides and Macrocycle Drug Discovery: Services and Platforms Market by Roots Analysis

To order this detailed 180+ page report, please visit this – https://www.rootsanalysis.com/reports/view_document/peptides-and-macrocycle-discovery/300.html Key Inclusions A detailed assessment of the current …

Read More

08

Sep'21

Digital Health Market: Focus on Digital Therapeutics by Roots Analysis

Recent advances in information technology and biomedical science have enabled the development of a number of versatile digital solutions that …

Read More
Copyrights © 2020 Blavida.
Skip to toolbar